A pharmaceutical company paid private investigators to gather personal information about high-ranking FDA officials, reports Politico. The company, which at the time was trying to gain FDA approval for a drug to treat blood clots, said it wanted to find out if the two FDA officials were "unfairly favoring a competitor in the drug approval process."
A new survey finds that white homeowners are 50 percent more likely than blacks to receive loan modifications that would help prevent forclosure, according to The Washington Independent.
Current rules regulating toxins in consumer products are weak and do not require companies to release much safety data, reports The New York Times. Some denture creams, for instance, contain high levels of zinc -- which has been linked to neurological problems -- yet manage to stay on store shelves.
In 2009, corrections inspectors gave a Florida jail a score of 100 percent, but in the past 15 months two inmates have escaped, one guard went to prison, two guards await trial and 30 jail workers received "the most sweeping employee discipline in the country," reports the Orlando Sentinel.
A third New Orleans police officer is expected to plead guilty today to helping cover up a police shooting of six civilians after Hurricane Katrina, the Times-Picayune reports.
As the Obama administration focuses on detention and deportation of undocumented immigrants with criminal histories, many legal permanent residents with minor drug offenses find themselves facing deportation as well, according to The New York Times.
These stories are part of our ongoing roundup of investigations from other news outlets. For more, visit our Investigations Elsewherepage.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit us. In the byline, we prefer “Author Name, ProPublica.” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.
Copy and paste the following into your page to republish: